Oral Delivery of Astaxanthin via Carboxymethyl Chitosan-Modified Nanoparticles for Ulcerative Colitis Treatment

The oral delivery strategy of natural anti-oxidant and anti-inflammatory agents has attracted great attention to improve the effectiveness of ulcerative colitis (UC) treatment. Herein, we developed a novel orally deliverable nanoparticle, carboxymethyl chitosan (CMC)-modified astaxanthin (AXT)-loade...

全面介绍

书目详细资料

发表在:	Molecules
Main Authors:	Wen Zhang, Xinping Zhang, Xinyi Lv, Ao Qu, Wenjing Liang, Limin Wang, Pei Zhao, Zijian Wu
格式:	文件
语言:	英语
出版:	MDPI AG 2024-03-01
主题:	astaxanthin carboxymethyl chitosan nanoparticle anti-inflammatory ulcerative colitis
在线阅读:	https://www.mdpi.com/1420-3049/29/6/1291